Leerink Partnrs Brokers Reduce Earnings Estimates for Humana

Humana Inc. (NYSE:HUM) – Analysts at Leerink Partnrs decreased their FY2025 earnings per share estimates for Humana in a research report issued on Wednesday, November 5th. Leerink Partnrs analyst W. Mayo now expects that the insurance provider will post earnings of $17.22 per share for the year, down from their previous forecast of $17.26. The consensus estimate for Humana’s current full-year earnings is $16.47 per share. Leerink Partnrs also issued estimates for Humana’s Q1 2026 earnings at $11.76 EPS, Q2 2026 earnings at $5.64 EPS and FY2028 earnings at $34.54 EPS.

Several other research firms also recently commented on HUM. Bank of America raised their price objective on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research report on Friday, October 10th. Royal Bank Of Canada raised their price target on Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a report on Thursday, August 21st. Wells Fargo & Company lifted their price objective on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Piper Sandler lowered their target price on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Finally, Sanford C. Bernstein raised their target price on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $299.22.

Humana Stock Performance

Shares of NYSE HUM opened at $251.70 on Friday. The company has a market cap of $30.27 billion, a P/E ratio of 19.32, a P/E/G ratio of 1.71 and a beta of 0.42. Humana has a 52-week low of $206.87 and a 52-week high of $315.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The firm’s fifty day moving average is $279.09 and its two-hundred day moving average is $258.85.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter last year, the business posted $4.16 earnings per share. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently modified their holdings of the business. Massachusetts Financial Services Co. MA grew its holdings in shares of Humana by 273.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock worth $907,541,000 after purchasing an additional 2,553,509 shares during the last quarter. Norges Bank bought a new stake in Humana during the 2nd quarter valued at about $397,079,000. Vanguard Group Inc. boosted its position in Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after buying an additional 1,143,662 shares during the period. AQR Capital Management LLC grew its stake in Humana by 3,257.5% in the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock worth $307,624,000 after acquiring an additional 1,127,973 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Humana by 161.5% during the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock worth $446,911,000 after acquiring an additional 1,060,767 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.